Merck KGaA (MKKGY)
(Delayed Data from OTC)
$25.39 USD
+0.85 (3.46%)
Updated Aug 8, 2025 03:59 PM ET
4-Sell of 5 4
A Value B Growth D Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MKKGY 25.39 +0.85(3.46%)
Will MKKGY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MKKGY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MKKGY
MKKGY or STVN: Which Is the Better Value Stock Right Now?
Merck KGaA (MKKGY) Upgraded to Strong Buy: Here's Why
MKKGY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should Value Investors Buy Merck KGaA (MKKGY) Stock?
MKKGY vs. ZTS: Which Stock Is the Better Value Option?
Are Investors Undervaluing Merck KGaA (MKKGY) Right Now?
Other News for MKKGY
Merck KGaA 2025 Q2 - Results - Earnings Call Presentation
Merck KGaA (MKGAF) Q2 2025 Earnings Call Transcript
Merck KGaA gives Q2 results
Merck KGaA: The Undervaluation Is Now Close To 13-Year Lows
Merck KGaA price target lowered by EUR 34 at Deutsche Bank